Nice Guidance: Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people

Psoriasisplaque
Image: Google Images

Adalimumab, Etanercept & Ustekinumab are recommended as an option for treating plaque psoriasis in children and young people aged 4 years or older, only if the disease:

  • is severe, as defined by a total Psoriasis Area and Severity Index (PASI) of 10 or more and
  • has not responded to standard systemic therapy, such as ciclosporin, methotrexate or phototherapy, or these options are contraindicated or not tolerated.

     

    Link to guidance here

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s